Antithrombotic therapies (Chapter 18) - The Stroke Book
The Optimal Antithrombotic Dose of Aspirin
Early Aspirin Discontinuation After Coronary Stenting: A Systematic Review and Meta‐Analysis | Journal of the American Heart Association
Optimizing low-dose aspirin therapy Suggested action Reference Clinical... | Download Table
Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs | PNAS
Low-Dose Aspirin for the Prevention of Atherothrombosis | NEJM
Aspirin as an Antiplatelet Drug | NEJM
Antiplatelet therapy in peripheral arterial disease. Consensus statement - ScienceDirect
Davide Capodanno on Twitter: "Secondary prevention with antithrombotic strategies that are not limited to aspirin monotherapy is an emerging paradigm. After excluding features of a high bleeding risk, patients with additional risk
Aspirin antiplatelet effects are associated with body weight - ScienceDirect
Antiplatelet Drugs
Doses of antiplatelet co-therapies | Download Table
Potential causes of a reduced antiplatelet effect of aspirin. ACE =... | Download Scientific Diagram
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
Antiplatelet therapy in coronary artery disease
Aspirin - Wikipedia
Antiplatelet Therapy in Acute Coronary Syndrome | ECR Journal
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials - The Lancet
The art of delivering evidence-based dual antiplatelet therapy | MDedge Family Medicine
Dose- and time-dependent antiplatelet effects of aspirin Christina Perneby, N. Håkan Wallén, Cathy Rooney, Desmond Fitzgerald, Paul Hjemdahl Published. - ppt download
Antiplatelet effect of aspirin during 24h in patients with type 2 diabetes without cardiovascular disease. | Semantic Scholar
